365 related articles for article (PubMed ID: 23129054)
21. CRISPR-Cas9-modified pfmdr1 protects Plasmodium falciparum asexual blood stages and gametocytes against a class of piperazine-containing compounds but potentiates artemisinin-based combination therapy partner drugs.
Ng CL; Siciliano G; Lee MC; de Almeida MJ; Corey VC; Bopp SE; Bertuccini L; Wittlin S; Kasdin RG; Le Bihan A; Clozel M; Winzeler EA; Alano P; Fidock DA
Mol Microbiol; 2016 Aug; 101(3):381-93. PubMed ID: 27073104
[TBL] [Abstract][Full Text] [Related]
22. A novel fungal metabolite inhibits Plasmodium falciparum transmission and infection.
Niu G; Wang X; Hao Y; Kandel S; Niu G; Raptis RG; Li J
Parasit Vectors; 2021 Mar; 14(1):177. PubMed ID: 33761961
[TBL] [Abstract][Full Text] [Related]
23. Nasal immunization with a malaria transmission-blocking vaccine candidate, Pfs25, induces complete protective immunity in mice against field isolates of Plasmodium falciparum.
Arakawa T; Komesu A; Otsuki H; Sattabongkot J; Udomsangpetch R; Matsumoto Y; Tsuji N; Wu Y; Torii M; Tsuboi T
Infect Immun; 2005 Nov; 73(11):7375-80. PubMed ID: 16239536
[TBL] [Abstract][Full Text] [Related]
24. Chemical signatures and new drug targets for gametocytocidal drug development.
Sun W; Tanaka TQ; Magle CT; Huang W; Southall N; Huang R; Dehdashti SJ; McKew JC; Williamson KC; Zheng W
Sci Rep; 2014 Jan; 4():3743. PubMed ID: 24434750
[TBL] [Abstract][Full Text] [Related]
25. Combination therapy counteracts the enhanced transmission of drug-resistant malaria parasites to mosquitoes.
Hallett RL; Sutherland CJ; Alexander N; Ord R; Jawara M; Drakeley CJ; Pinder M; Walraven G; Targett GA; Alloueche A
Antimicrob Agents Chemother; 2004 Oct; 48(10):3940-3. PubMed ID: 15388456
[TBL] [Abstract][Full Text] [Related]
26. Repurposing of existing therapeutics to combat drug-resistant malaria.
Yadav K; Shivahare R; Shaham SH; Joshi P; Sharma A; Tripathi R
Biomed Pharmacother; 2021 Apr; 136():111275. PubMed ID: 33485067
[TBL] [Abstract][Full Text] [Related]
27. Screening the Pathogen Box for Inhibition of Plasmodium falciparum Sporozoite Motility Reveals a Critical Role for Kinases in Transmission Stages.
Kanatani S; Elahi R; Kanchanabhogin S; Vartak N; Tripathi AK; Prigge ST; Sinnis P
Antimicrob Agents Chemother; 2022 Sep; 66(9):e0041822. PubMed ID: 35943271
[TBL] [Abstract][Full Text] [Related]
28. MEFAS, a hybrid of artesunate-mefloquine active against asexual stages of Plasmodium vivax in field isolates, inhibits malaria transmission.
Penna-Coutinho J; da Silva Araújo M; Campos Aguiar AC; Sá PM; Rios CT; Medeiros JF; Pereira DB; Boechat N; Krettli AU
Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():150-155. PubMed ID: 34637981
[TBL] [Abstract][Full Text] [Related]
29. Gene targeting in the rodent malaria parasite Plasmodium yoelii.
Mota MM; Thathy V; Nussenzweig RS; Nussenzweig V
Mol Biochem Parasitol; 2001 Apr; 113(2):271-8. PubMed ID: 11295181
[TBL] [Abstract][Full Text] [Related]
30. A simple and predictive phenotypic High Content Imaging assay for Plasmodium falciparum mature gametocytes to identify malaria transmission blocking compounds.
Lucantoni L; Silvestrini F; Signore M; Siciliano G; Eldering M; Dechering KJ; Avery VM; Alano P
Sci Rep; 2015 Nov; 5():16414. PubMed ID: 26553647
[TBL] [Abstract][Full Text] [Related]
31. Gametocytocidal screen identifies novel chemical classes with Plasmodium falciparum transmission blocking activity.
Sanders NG; Sullivan DJ; Mlambo G; Dimopoulos G; Tripathi AK
PLoS One; 2014; 9(8):e105817. PubMed ID: 25157792
[TBL] [Abstract][Full Text] [Related]
32. A class of potent antimalarials and their specific accumulation in infected erythrocytes.
Wengelnik K; Vidal V; Ancelin ML; Cathiard AM; Morgat JL; Kocken CH; Calas M; Herrera S; Thomas AW; Vial HJ
Science; 2002 Feb; 295(5558):1311-4. PubMed ID: 11847346
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of the SR protein-phosphorylating CLK kinases of Plasmodium falciparum impairs blood stage replication and malaria transmission.
Kern S; Agarwal S; Huber K; Gehring AP; Strödke B; Wirth CC; Brügl T; Abodo LO; Dandekar T; Doerig C; Fischer R; Tobin AB; Alam MM; Bracher F; Pradel G
PLoS One; 2014; 9(9):e105732. PubMed ID: 25188378
[TBL] [Abstract][Full Text] [Related]
34. A polymorphic drug pump in the malaria parasite.
Saliba KJ; Lehane AM; Kirk K
Mol Microbiol; 2008 Nov; 70(4):775-9. PubMed ID: 18990178
[TBL] [Abstract][Full Text] [Related]
35. Transmission-blocking activity induced by malaria vaccine candidates Pfs25/Pvs25 is a direct and predictable function of antibody titer.
Miura K; Keister DB; Muratova OV; Sattabongkot J; Long CA; Saul A
Malar J; 2007 Aug; 6():107. PubMed ID: 17686163
[TBL] [Abstract][Full Text] [Related]
36. A Malaria Transmission-Blocking (+)-Usnic Acid Derivative Prevents Plasmodium Zygote-to-Ookinete Maturation in the Mosquito Midgut.
Pastrana-Mena R; Mathias DK; Delves M; Rajaram K; King JG; Yee R; Trucchi B; Verotta L; Dinglasan RR
ACS Chem Biol; 2016 Dec; 11(12):3461-3472. PubMed ID: 27978709
[TBL] [Abstract][Full Text] [Related]
37. Transmission-blocking drugs for malaria elimination.
Birkholtz LM; Alano P; Leroy D
Trends Parasitol; 2022 May; 38(5):390-403. PubMed ID: 35190283
[TBL] [Abstract][Full Text] [Related]
38. In vitro Multistage Malaria Transmission Blocking Activity of Selected Malaria Box Compounds.
Malebo HM; D'Alessandro S; Ebstie YA; Sorè H; Tenoh Guedoung AR; Katani SJ; Parapini S; Taramelli D; Habluetzel A
Drug Des Devel Ther; 2020; 14():1593-1607. PubMed ID: 32425505
[TBL] [Abstract][Full Text] [Related]
39. Carboxypeptidases B of Anopheles gambiae as targets for a Plasmodium falciparum transmission-blocking vaccine.
Lavazec C; Boudin C; Lacroix R; Bonnet S; Diop A; Thiberge S; Boisson B; Tahar R; Bourgouin C
Infect Immun; 2007 Apr; 75(4):1635-42. PubMed ID: 17283100
[TBL] [Abstract][Full Text] [Related]
40. That was then but this is now: malaria research in the time of an eradication agenda.
Kappe SH; Vaughan AM; Boddey JA; Cowman AF
Science; 2010 May; 328(5980):862-6. PubMed ID: 20466924
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
